title: Suspected YF-AND after yellow fever vaccination in Finland.
abstract: Yellow fever (YF) vaccine is considered safe but vaccine-associated complications have also been encountered. We report neurological symptoms after YF-vaccination in a previously healthy Finnish male. Other concomitant infections or causes for the symptoms could not be identified.
authors.affiliation: HUSLAB, Department of Virology and Immunology, Helsinki University Central Hospital, Finland; Haartman Institute, Department of Virology, University of Helsinki, Finland. Electronic address: anne.jaaskelainen@helsinki.fi.
authors.forename: Anne J
authors.initials: AJ
authors.lastname: Jääskeläinen
authors.affiliation: Haartman Institute, Department of Virology, University of Helsinki, Finland.
authors.forename: Eili
authors.initials: E
authors.lastname: Huhtamo
authors.affiliation: Department of Neurology, Helsinki University Central Hospital, and Molecular Neurology, Research Programs Unit, Biomedicum, University of Helsinki, Helsinki, Finland.
authors.forename: Reetta
authors.initials: R
authors.lastname: Kivioja
authors.affiliation: Centre for Biological Threats and Special Pathogens, Highly Pathogenic Viruses, Robert Koch Institute, Berlin, Germany.
authors.forename: Cristina
authors.initials: C
authors.lastname: Domingo
authors.affiliation: Public Health Agency of Sweden, Solna, Sweden.
authors.forename: Sirkka
authors.initials: S
authors.lastname: Vene
authors.affiliation: HUSLAB, Department of Virology and Immunology, Helsinki University Central Hospital, Finland; Haartman Institute, Department of Virology, University of Helsinki, Finland.
authors.forename: Hannimari
authors.initials: H
authors.lastname: Kallio-Kokko
authors.affiliation: Centre for Biological Threats and Special Pathogens, Highly Pathogenic Viruses, Robert Koch Institute, Berlin, Germany.
authors.forename: Matthias
authors.initials: M
authors.lastname: Niedrig
authors.affiliation: Department of Neurology, Helsinki University Central Hospital, and Molecular Neurology, Research Programs Unit, Biomedicum, University of Helsinki, Helsinki, Finland.
authors.forename: Pentti J
authors.initials: PJ
authors.lastname: Tienari
authors.affiliation: HUSLAB, Department of Virology and Immunology, Helsinki University Central Hospital, Finland; Haartman Institute, Department of Virology, University of Helsinki, Finland; Faculty of Veterinary Medicine, Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.
authors.forename: Olli
authors.initials: O
authors.lastname: Vapalahti
mesh_terms: D000914:Antibodies, Viral / Q000097:blood; D005387:Finland; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000235:genetics / Q000302:isolation & purification; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013997:Time Factors; D014611:Vaccination / Q000009:adverse effects*; D015004:Yellow Fever / Q000139:chemically induced* / Q000175:diagnosis* / Q000517:prevention & control; D022341:Yellow Fever Vaccine / Q000008:administration & dosage* / Q000009:adverse effects*; D015005:Yellow fever virus / Q000302:isolation & purification
chemical_list: D000914:Antibodies, Viral; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D012367:RNA, Viral; D022341:Yellow Fever Vaccine
keywords: Adverse reaction; Vaccination; Yellow fever